BFC
MDCO

Bedel Financial Consulting’s Medicines Co MDCO Stock Holding History

Bedel Financial Consulting’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-157
Closed -$13K – 947
2019
Q4 		$13K Hold
157
– – 0.01% 464
2019
Q3 		$8K Hold
157
– – ﹤0.01% 524
2019
Q2 		$6K Hold
157
– – ﹤0.01% 558
2019
Q1 		$4K Buy
+157
New +$3.7K ﹤0.01% 601

Other funds holding MDCO

GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Bedel Financial Consulting's MDCO Position: Q1 2020 in Review

Bedel Financial Consulting sold out of Medicines Co (MDCO) in Q1 2020, closing a stake of 157 shares — an estimated $13K sold.

Bedel Financial Consulting first reported a position in MDCO in Q1 2019 and held it in 4 quarters. The position peaked at $13K in Q4 2019. 1 fund tracked by Wall St. Rank holds MDCO as of Q1 2020.

  • Bedel Financial Consulting reported no remaining Medicines Co position as of Q1 2020 after selling out during the quarter.
  • Bedel Financial Consulting sold 157 Medicines Co shares in Q1 2020, an estimated $13K.
  • Bedel Financial Consulting first reported a position in Medicines Co in Q1 2019 and held it in 4 quarters.
  • Bedel Financial Consulting's Medicines Co position peaked at $13K in Q4 2019.
  • 1 fund tracked by Wall St. Rank held Medicines Co as of Q1 2020.

Based on Bedel Financial Consulting's 13F filing for Q1 2020, filed 6 May 2020.